In May 2022, Italy introduced a new national transparency law designed to regulate relationships between pharmaceutical and medical device manufacturers and individuals or organizations in the healthcare sector. The law aims to increase transparency around financial relationships between manufacturers and healthcare professionals, helping to combat corruption and promote accountability.
Recent Posts
- File XML, Portale Impresa e piattaforma del Ministero della Salute: una guida tecnica in linguaggio semplice per i professionisti della compliance
- XML Files, Portale Impresa, and the Ministry of Health Platform: A Plain-Language Technical Guide for Compliance Officers
- Why XML Reporting May Become the Biggest Readiness Challenge Under Italy’s Sunshine Act
- Perché la rendicontazione XML potrebbe diventare la principale sfida di preparazione al Sunshine Act italiano
- Does Your Italian Affiliate Know About Every Clinical Study Paying Your HCPs? It Should.